1[1]Cavero PG,Miller WL,Heablein DM,et al.Endothelinin experimental CHF in the anesthetized dog[J].Am J Physiol,1990,28(9):312-313.
2[2]Tsutamoto T,Hisanaga T.Prognostic value of plasma soluble intercellular adhesion molecule-1 and ET-1 concentrations in patients with chnonic congestive heart failure[J].Am J Candiol,1995,76(5):803.
5[1]Yndestad A,Damas JK,Oie E,et al.Role of inflammation in the progression of heart failure[J].Curr Cardiol Rep,2007,9(3):236-241.
6[3]Miranda HR,Castro GP,Verdejo PH,et al.Oxidative stress and inflammation in heart failure:mechanisms of damage and therapeutic alternatives[J].Rev Med Chil,2007,135(8):1056-1063.
7[4]Marcucci R,Gori AM,Giannotti F,et al.Markers of hypercoagulability and inflammation predict mortality in patients with heart failure[J].J Thromb Haemost,2006,4(5):1017-1022.
8[5]Kanda T,Takahashi T.Interleukin-6 and cardiovascular diseases[J].Jpn Heart J,2004,45(2):183-193.
9[6]Lamblin N,Mouquet F,Hennache B,et al.High-sensitivity C-reactive protein:potential adjunct for risk stratification in patients with stable congestive heart failure[J].Eur Heart J,2005,26(21):2245-2250.
